SAM
WST icon

Smartleaf Asset Management’s West Pharmaceutical WST Stock Holding History

Smartleaf Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$422K Hold
1,190
– – 0.01% 599
2026
Q1 		$292K Sell
1,190
-17
-1% -$4.23K 0.01% 665
2025
Q4 		$334K Buy
1,207
+53
+5% +$14.5K 0.01% 618
2025
Q3 		$300K Buy
1,154
+354
+44% +$86K 0.02% 604
2025
Q2 		$175K Sell
800
-36
-4% -$7.7K 0.02% 618
2025
Q1 		$186K Sell
836
-78
-9% -$21.5K 0.02% 598
2024
Q4 		$301K Buy
914
+248
+37% +$78K 0.03% 437
2024
Q3 		$207K Buy
666
+114
+21% +$34.9K 0.03% 487
2024
Q2 		$181K Buy
552
+56
+11% +$19.8K 0.03% 409
2024
Q1 		$195K Buy
496
+32
+7% +$11.8K 0.04% 363
2023
Q4 		$165K Buy
+464
New +$164K 0.04% 348

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Smartleaf Asset Management's WST Position: Q2 2026 in Review

Smartleaf Asset Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 1,190 shares worth $422K. The position accounts for 0.01% of the portfolio, ranked #599.

Smartleaf Asset Management first reported a position in WST in Q4 2023 and has held it in 11 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Smartleaf Asset Management held 1,190 shares of West Pharmaceutical worth $422K as of Q2 2026.
  • Smartleaf Asset Management left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #599 holding.
  • Smartleaf Asset Management first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.